IP Library Granted Patent US 8,962,285
Granted Patent B2
US 8,962,285 · App. 13/525,048 · Granted Feb 24, 2015

Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,285
App. No.
13/525,048
Granted
Feb 24, 2015
Kind
B2
Abstract

The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize chiral compounds.

Claims (10)

1. A method for stereoselectively reducing substrate 3-ketothiolane-to product (R)-3-hydroxythiolane, which comprises contacting the 3-ketothiolane with the ketoreductase polypeptide comprising an amino acid sequence that is at least 90% identical to the reference sequence SEQ ID NO:4 and which has a serine at the residue position corresponding to X145, under suitable reaction conditions for reducing or converting the 3-ketothiolase to (R)-3-hydroxythiolane, with a stereomeric excess of at least 90%.

2. The method of claim 1 , wherein 3-ketothiolane is reduced to (R)-3-hydroxythiolane with at least about 98% steromeric excess.

3. The method of claim 1 , wherein the substrate is at least 100 g/L and at least 90% of the substrate is converted to product in less than 24 hrs, wherein the ketoreductase polypeptide is at least about 0.8-1.0 g/L and comprises SEQ ID NO:98.

4. The method of claim 1 , wherein the substrate is at least 100 g/L and at least 90% of the substrate is converted to product in less than 20 hrs, wherein the ketoreductase polypeptide is at least about 0.8-1.0 g/L and is selected from the group consisting of SEQ ID NO:26, 44, 68, and 104.

5. The method of claim 1 which is carried out at pH of about 7.5 or less.

6. The method of claim 1 which is carried out at a pH of from about 5.0 to about 7.5.

7. The method of claim 1 which is carried out with whole cells that express the ketoreductase enzyme, or an extract or lysate of such cells.

8. The method of claim 1 in which the ketoreductase is isolated and/or purified and the reduction reaction is carried out in the presence of a cofactor for the ketoreductase and optionally a regeneration system for the cofactor.

9. The method of claim 8 in which the cofactor regenerating system comprises glucose dehydrogenase and glucose; formate dehydrogenase and formate; or isopropanol and a secondary alcohol dehydrogenase.

10. The method of claim 9 , wherein the secondary alcohol dehydrogenase is the ketoreductase.

Assignments (4)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2024
From: CODEXIS, INC.
To: PFIZER, INC.
Reel/Frame 066424/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2024
From: PFIZER, INC.
To: CODEXIS, INC.
Reel/Frame 066424/0806 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2024
From: LIANG, JACK; JENNE, STEPHANE J.; MUNDORFF, EMILY; LALONDE, JAMES; VOLADRI, RAMA; HUISMAN, GJALT
To: CODEXIS, INC.
Reel/Frame 066418/0055 →